Abiopharma

Praxis Precisions Medicines Inc (PRAX) Announces Executive and Board Changes Praxis Precisions Medicines Inc (PRAX) announced changes to its leadership team and board of directors. Directors or was appointed. The position includes: Class II, Governance Committee, Board committee, Nominating and Corporate Governance Committee. The change is effective as of January 8, 2026. The term will expire in 2028. Executive Changes Details:

• Personnel Involved: Directors or, Principal Officers, Megan Sniecinski
• Actions: Appointed, Elected
• Committee Assignments: Governance Committee, Board committee, Nominating and Corporate Governance Committee
• Effective Date: January 8, 2026
• Board Classification: Class II